Sort by
Refine Your Search
-
Category
-
Field
-
://indiana.peopleadmin.com/postings/24325 Basic Qualifications Doctorate or Terminal degree is required. A PhD, MD, or equivalent and evidence of expertise in molecular mechanisms of disease. Department Contact for Questions
-
Center (IUSCCC; https://cancer.iu.edu/index.html) and the Director of Graduate Studies for the Cell and Molecular Cancer Biology (CMCB) PhD program (https://medicine.iu.edu/boomington/graduate-programs
-
for one or more outstanding, highly motivated post-doctoral research fellows with special interest in human genomics/computational systems biology to work on multi-omics analyses of Alzheimer’s disease and
-
discovered populations of pulmonary endothelial cells in the pathobiology of PH and investigation of heme-mediated signaling mechanisms. Dr. Rafikova’s lab research focuses on the role of mitochondrial
-
fellows with special interest in human connectomics in Alzheimer’s disease (AD). The Lab’s overarching goals are 1) to achieve a better understanding of the brain network and neurophysiological mechanisms
-
dysfunction, mechanisms of immune regulation, and sex differences in PH. The successful candidate will be actively involved in ongoing multi-project settings in a highly productive research environment
-
together to achieve success in fulfilling the tripartite mission. The department has over 100 faculty members with a primary appointment in pathology, 80 of whom are dually employed pathologists and PhD
-
these model system to determine cellular networks that lead to cell death and to establish molecules that can prevent degeneration. Our dynamic inner ear research group includes Rick Nelson MD PhD and Eri
-
Center (IUSCCC; https://cancer.iu.edu/index.html) and the Director of Graduate Studies for the Cell and Molecular Cancer Biology (CMCB) PhD program (https://medicine.iu.edu/boomington/graduate-programs
-
for one or more outstanding, highly motivated post-doctoral research fellows with special interest in human genomics/computational systems biology to work on multi-omics analyses of Alzheimer’s disease and